Sirolimus Loaded Chitosan Functionalized PLGA Nanoparticles Protect Against Sodium Iodate-Induced Retinal Degeneration

[1]  Ching-Li Tseng,et al.  Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye , 2022, Pharmaceutics.

[2]  A. Salmon,et al.  Short term treatment with a cocktail of rapamycin, acarbose and phenylbutyrate delays aging phenotypes in mice , 2022, Scientific Reports.

[3]  S. Priglinger,et al.  Anti-angiogenic properties of rapamycin on human retinal pericytes in an in vitro model of neovascular AMD via inhibition of the mTOR pathway , 2022, BMC Ophthalmology.

[4]  Yen-Ju Chen,et al.  The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases , 2022, Cell & Bioscience.

[5]  Chen Jiang,et al.  Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation , 2021, Acta pharmaceutica Sinica. B.

[6]  A. Chauhan,et al.  Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan , 2021, Pharmaceutics.

[7]  G. Jain,et al.  Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid) (PLGA) nanoparticles for potential treatment of age-related macular degeneration. , 2021, International journal of biological macromolecules.

[8]  Ji Wang,et al.  Protective effect of rapamycin in models of retinal degeneration. , 2021, Experimental eye research.

[9]  T. Nag.  Pathogenic mechanisms contributing to the vulnerability of aging human photoreceptor cells , 2021, Eye.

[10]  Pamela M. Martin,et al.  Oxidative Stress and Inflammation in Retinal Degeneration , 2021, Antioxidants.

[11]  Jer-An Lin,et al.  Protective Effect of Quercetin on Sodium Iodate-Induced Retinal Apoptosis through the Reactive Oxygen Species-Mediated Mitochondrion-Dependent Pathway , 2021, International journal of molecular sciences.

[12]  R. Salceda,et al.  Retinal Nrf2 expression in normal and early streptozotocin-diabetic rats , 2021, Neurochemistry International.

[13]  J. Chhablani,et al.  Intravitreal sirolimus for persistent, exudative age-related macular degeneration: a Pilot Study , 2021, International Journal of Retina and Vitreous.

[14]  David M. Wu,et al.  Nrf2 overexpression rescues the RPE in mouse models of retinitis pigmentosa , 2021, JCI insight.

[15]  T. Mehta,et al.  Intranasal delivery of chitosan decorated PLGA core /shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer's disease , 2020 .

[16]  Bin Fan,et al.  Autophagy in Age-Related Macular Degeneration: A Regulatory Mechanism of Oxidative Stress , 2020, Oxidative medicine and cellular longevity.

[17]  Dean P. Jones,et al.  MTOR‐initiated metabolic switch and degeneration in the retinal pigment epithelium , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Xu Zhang,et al.  Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model. , 2020, European journal of pharmacology.

[19]  C. Punzo,et al.  Altered photoreceptor metabolism in mouse causes late stage age-related macular degeneration-like pathologies , 2020, Proceedings of the National Academy of Sciences.

[20]  Yusen Huang,et al.  Autophagy attenuates high glucose-induced oxidative injury to lens epithelial cells , 2020, Bioscience reports.

[21]  Sneha Gupta,et al.  Changes in the Inner Retinal Cells after Intense and Constant Light Exposure in Sprague‐Dawley Rats , 2020, Photochemistry and photobiology.

[22]  S. Beg,et al.  Target strategies for drug delivery bypassing ocular barriers , 2020 .

[23]  A. Salminen,et al.  The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology , 2019, International journal of molecular sciences.

[24]  T. Nag,et al.  Age-related changes of the human retinal vessels: possible involvement of lipid peroxidation. , 2019, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[25]  R. Agrawal,et al.  Hollow Microcapsules as Periocular Drug Depot for Sustained Release of Anti-VEGF Protein , 2019, Pharmaceutics.

[26]  C. Luu,et al.  Retinal degeneration rat model: A study on the structural and functional changes in the retina following injection of sodium iodate. , 2019, Journal of photochemistry and photobiology. B, Biology.

[27]  H. Chang,et al.  mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV , 2019, Cell Communication and Signaling.

[28]  E. Denkbaş,et al.  Transscleral Delivery of Bevacizumab-Loaded Chitosan Nanoparticles. , 2019, Journal of biomedical nanotechnology.

[29]  D. Vollrath,et al.  Abnormal mTORC1 signaling leads to retinal pigment epithelium degeneration , 2019, Theranostics.

[30]  S. Fialho,et al.  Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits’ eyes , 2018, Documenta Ophthalmologica.

[31]  C. Silva-Islas,et al.  Canonical and non‐canonical mechanisms of Nrf2 activation , 2018, Pharmacological research.

[32]  H. Hara,et al.  Irreversible Photoreceptors and RPE Cells Damage by Intravenous Sodium Iodate in Mice Is Related to Macrophage Accumulation. , 2018, Investigative ophthalmology & visual science.

[33]  Venkateshwaran Krishnaswami,et al.  Biological macromolecules for ophthalmic drug delivery to treat ocular diseases. , 2018, International journal of biological macromolecules.

[34]  E. Chew,et al.  Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study. , 2017, Ophthalmology. Retina.

[35]  Jost B. Jonas,et al.  Updates on the Epidemiology of Age‐Related Macular Degeneration , 2017, Asia-Pacific journal of ophthalmology.

[36]  R. Podolsky,et al.  Sodium Iodate Produces a Strain-Dependent Retinal Oxidative Stress Response Measured In Vivo Using QUEST MRI , 2017, Investigative ophthalmology & visual science.

[37]  A. Urtti,et al.  Pharmacokinetic aspects of retinal drug delivery , 2017, Progress in Retinal and Eye Research.

[38]  S. Venkatraman,et al.  Drug delivery to the eye: what benefits do nanocarriers offer? , 2017, Nanomedicine.

[39]  M. DeAngelis,et al.  Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors , 2016, Eye and Vision.

[40]  B. Chan,et al.  Sustained Delivery of Bioactive GDNF from Collagen and Alginate-Based Cell-Encapsulating Gel Promoted Photoreceptor Survival in an Inherited Retinal Degeneration Model , 2016, PloS one.

[41]  D. Sarraf,et al.  Retinal pigment epithelial cell necroptosis in response to sodium iodate , 2016, Cell Death Discovery.

[42]  R. T. Smith,et al.  Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review , 2016, Ophthalmic Research.

[43]  K. Tsubota,et al.  The Neuroprotective Effect of Rapamycin as a Modulator of the mTOR-NF-κB Axis during Retinal Inflammation , 2016, PloS one.

[44]  U. Pleyer,et al.  Sirolimus for the treatment of noninfectious uveitis , 2016, Expert opinion on pharmacotherapy.

[45]  Shusheng Wang,et al.  RPE necroptosis in response to oxidative stress and in AMD , 2015, Ageing Research Reviews.

[46]  Shaozi Li,et al.  Protective effect of autophagy on human retinal pigment epithelial cells against lipofuscin fluorophore A2E: implications for age-related macular degeneration , 2015, Cell Death and Disease.

[47]  Volker Enzmann,et al.  Retinal Cell Death Caused by Sodium Iodate Involves Multiple Caspase-Dependent and Caspase-Independent Cell-Death Pathways , 2015, International journal of molecular sciences.

[48]  L. Serpell,et al.  Dementia of the eye: the role of amyloid beta in retinal degeneration , 2015, Eye.

[49]  S. Mitter,et al.  Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD , 2014, Autophagy.

[50]  M. Mishra,et al.  Epigenetic modifications of Nrf2-mediated glutamate-cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression. , 2014, Free radical biology & medicine.

[51]  Y. Kurauchi,et al.  Rapamycin prevents N‐methyl‐D‐aspartate‐induced retinal damage through an ERK‐dependent mechanism in rats , 2014, Journal of neuroscience research.

[52]  M. Saint-Geniez,et al.  Direct effect of sodium iodate on neurosensory retina. , 2014, Investigative ophthalmology & visual science.

[53]  C. Pang,et al.  Assessing sodium iodate-induced outer retinal changes in rats using confocal scanning laser ophthalmoscopy and optical coherence tomography. , 2014, Investigative ophthalmology & visual science.

[54]  R. Klein,et al.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. , 2014, The Lancet. Global health.

[55]  H. Flynn,et al.  Drug delivery techniques for treating age-related macular degeneration , 2014, Expert opinion on drug delivery.

[56]  Yuhua Weng,et al.  Sustained release of Avastin® from polysaccharides cross-linked hydrogels for ocular drug delivery. , 2013, International journal of biological macromolecules.

[57]  M. Mishra,et al.  Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. , 2013, Investigative ophthalmology & visual science.

[58]  Tanya S. Glaser,et al.  Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial. , 2013, Investigative ophthalmology & visual science.

[59]  C. Moon,et al.  Differential cell death and Bcl-2 expression in the mouse retina after glutathione decrease by systemic D,L-buthionine sulphoximine administration , 2013, Molecules and cells.

[60]  J. Naor,et al.  Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study , 2013, Journal of Ophthalmic Inflammation and Infection.

[61]  Z. Yin,et al.  The Influence of NaIO3-Induced Retinal Degeneration on Intra-retinal Layer and the Changes of Expression Profile/Morphology of DA-ACs and mRGCS , 2013, Molecular Neurobiology.

[62]  S. Jarrett,et al.  Consequences of oxidative stress in age-related macular degeneration. , 2012, Molecular aspects of medicine.

[63]  Brij B. Singh,et al.  Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina , 2011, BMC ophthalmology.

[64]  Chen Zhao,et al.  mTOR pathway activation in age-related retinal disease , 2011, Aging.

[65]  Xiyan Li,et al.  mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. , 2011, The Journal of clinical investigation.

[66]  A. Subrizi,et al.  Barrier analysis of periocular drug delivery to the posterior segment. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[67]  Clive G. Wilson,et al.  Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. , 2010, Investigative ophthalmology & visual science.

[68]  F. Ferris,et al.  A RANDOMIZED PILOT STUDY OF SYSTEMIC IMMUNOSUPPRESSION IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH CHOROIDAL NEOVASCULARIZATION , 2010, Retina.

[69]  D. Hu,et al.  Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells , 2010, Molecular vision.

[70]  T. Weichhart,et al.  The multiple facets of mTOR in immunity. , 2009, Trends in immunology.

[71]  W. Hauswirth,et al.  SOD2 knockdown mouse model of early AMD. , 2007, Investigative ophthalmology & visual science.

[72]  Y. Bae,et al.  Glutathione depletion induces differential apoptosis in cells of mouse retina, in vivo , 2007, Neuroscience Letters.

[73]  P. Beaune,et al.  Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction. , 2006, Kidney international.

[74]  U. Kompella,et al.  Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model. , 2005, European journal of pharmacology.

[75]  B. Godley,et al.  Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. , 2003, Experimental eye research.

[76]  Uday B Kompella,et al.  Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. , 2003, Investigative ophthalmology & visual science.

[77]  N. Shikata,et al.  Morphologic characteristics of retinal degeneration induced by sodium iodate in mice , 2002, Current eye research.

[78]  H F Edelhauser,et al.  Transscleral drug delivery for posterior segment disease. , 2001, Advanced drug delivery reviews.

[79]  Dean P. Jones,et al.  Oxidative damage and protection of the RPE , 2000, Progress in Retinal and Eye Research.

[80]  Jennifer I. Lim,et al.  Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. , 1995, Investigative ophthalmology & visual science.

[81]  Ehab Abdel Aziz Ahmed El-Shaarawy,et al.  Aging changes in the retina of male albino rat: a histological, ultrastructural and immunohistochemical study. , 2019, Folia morphologica.

[82]  F. Ferris,et al.  Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial. , 2014, Investigative ophthalmology & visual science.

[83]  J. McGinnis,et al.  Oxidative stress: the achilles' heel of neurodegenerative diseases of the retina. , 2012, Frontiers in bioscience.

[84]  U. Kompella,et al.  Modeling of corneal and retinal pharmacokinetics after periocular drug administration. , 2008, Investigative ophthalmology & visual science.

[85]  A. Ramé.  [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.